Integrated single-cell and bulk transcriptome analyses characterize CD8+ exhausted T-cell-associated prognostic features in colorectal cancer liver metastasis
Background Liver metastasis continues to be a critical factor contributing to adverse prognoses in colorectal cancer (CRC) and is significantly affected by an immunosuppressive tumor microenvironment (TME). While CD8 + exhausted T cells (CD8_Tex) are generally recognized as key elements in the attenuation of antitumor immunity, their precise functional role in colorectal cancer liver metastasis (CRLM) has yet to be comprehensively elucidated. Methods Single-cell RNA sequencing data from primary and metastatic lesions were integrated with bulk transcriptomic data from TCGA and GEO. Integrative bioinformatic analyses were used to characterize the biological features and clinical relevance of CD8_Tex cells in CRLM. In addition, the expression of key model genes was examined by RT-qPCR in colorectal cancer cell lines. Results We constructed a high-resolution single-cell atlas of CRLM. Based on genes upregulated in metastasis-associated CD8_Tex cells, we established a six-gene prognostic signature. This signature stratified patients into high- and low-risk groups with significantly different overall survival. Cell-cell communication analysis suggested enhanced interactions between fibroblasts and CD8_Tex cells in metastatic lesions, with APP-CD74 identified as a potential ligand-receptor interaction. Pseudotime analysis further suggested that key prognostic genes changed in parallel with exhaustion-related gene expression patterns. RT-qPCR in CRC cell lines provided preliminary experimental support for the dysregulated expression of the six model genes in CRC-related cellular contexts. Conclusion Collectively, our findings link CD8_Tex-associated remodeling to the immunosuppressive microenvironment of CRLM and identify a six-gene prognostic signature with potential value for risk stratification.
Authors
- Cheng Gu (ORCID: https://orcid.org/0000-0001-6429-7008)
- Qing Xu (ORCID: https://orcid.org/0000-0002-9804-3222)
- Rongjia Xie
- Zhui Ke (ORCID: https://orcid.org/0009-0009-0129-4518)
- Rong He
- Xiaolan Yin
- Jie Gao
Institutions
- Shanghai University (CN)
- Tongji University (CN)
- Shanghai Tenth People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-11-16
- DOI
- https://doi.org/10.3389/fonc.2026.2014957
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Shanghai Clinical Research Center